ADC Therapeutics SA

09/29/2021 | Press release | Distributed by Public on 09/29/2021 06:05

Overland ADCT BioPharma Announces First Patient Dosed in China with ZYNLONTA® in Pivotal Phase 2 Clinical Trial for Diffuse Large B-cell Lymphoma